|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ohashi S, Miyamoto S, Kikuchi O, Goto T,
Amanuma Y and Muto M: Recent advances from basic and clinical
studies of esophageal squamous cell carcinoma. Gastroenterology.
149:1700–1715. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pennathur A, Gibson MK, Jobe BA and
Luketich JD: Oesophageal carcinoma. Lancet. 381:400–412. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chang H, Shin SK, Cho BC, Lee CG, Kim CB,
Kim DJ, Lee JG, Hur J, Lee CY, Bae MK, et al: A prospective phase
II trial of S-1 and cisplatin-based chemoradiotherapy for
locoregionally advanced esophageal cancer. Cancer Chemother
Pharmacol. 73:665–671. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhu X, Li Z, Li T, Long F, Lv Y, Liu L,
Liu X and Zhan Q: Osthole inhibits the PI3K/AKT signaling pathway
via activation of PTEN and induces cell cycle arrest and apoptosis
in esophageal squamous cell carcinoma. Biomed Pharmacother.
102:502–509. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lin S, Lv J, Peng P, Cai C, Deng J, Deng
H, Li X and Tang X: Bufadienolides induce p53-mediated apoptosis in
esophageal squamous cell carcinoma cells in vitro and in
vivo. Oncol Lett. 15:1566–1572. 2018.PubMed/NCBI
|
|
8
|
Jiang JH, Pi J, Jin H, Yang F and Cai JY:
Chinese herb medicine matrine induce apoptosis in human esophageal
squamous cancer KYSE-150 cells through increasing reactive oxygen
species and inhibiting mitochondrial function. Pathol Res Pract.
214:691–699. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Siyo V, Schäfer G, Hunter R, Grafov A,
Grafova I, Nieger M, Katz AA, Parker MI and Kaschula CH: The
cytotoxicity of the ajoene analogue BisPMB in WHCO1 oesophageal
cancer cells is mediated by CHOP/GADD153. Molecules. 22:E8922017.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Brockmann H and Junge H: Die konstitution
des dracorhodins, eines neuen farbstoffes aus dem ‘Drachenblut’.
Berl Dtsch Chem Ges. 76:751–846. 1943. View Article : Google Scholar
|
|
11
|
Rao GS, Gerhart MA, Lee RT III, Mitscher
LA and Drake S: Antimicrobial agents from higher plants. Dragon's
blood resin. J Nat Prod. 45:646–648. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li F, Jiang T, Liu W, Hu Q and Yin H: The
angiogenic effect of dracorhodin perchlorate on human umbilical
vein endothelial cells and its potential mechanism of action. Mol
Med Rep. 14:1667–1672. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jiang XW, Qiao L, Liu L, Zhang BQ, Wang
XW, Han YW and Yu WH: Dracorhodin perchlorate accelerates cutaneous
wound healing in wistar rats. Evid Based Complement Alternat Med.
2017:89505162017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang LF, Liu X, Lv LL, Ma ZM, Feng XC and
Ma TH: Dracorhodin perchlorate inhibits biofilm formation and
virulence factors of Candida albicans. J Mycol Med. 28:36–44. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rasul A, Ding C, Li X, Khan M, Yi F, Ali M
and Ma T: Dracorhodin perchlorate inhibits PI3K/Akt and NF-κB
activation, up-regulates the expression of p53, and enhances
apoptosis. Apoptosis. 17:1104–1119. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xia M, Wang M, Tashiro S, Onodera S,
Minami M and Ikejima T: Dracorhodin perchlorate induces A375-S2
cell apoptosis via accumulation of p53 and activation of caspases.
Biol Pharm Bull. 28:226–232. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen X, Luo J, Meng L, Pan T, Zhao B, Tang
ZG and Dai Y: Dracorhodin perchlorate induces the apoptosis of
glioma cells. Oncol Rep. 35:2364–2372. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang G, Sun M, Zhang Y, Hua P, Li X, Cui
R and Zhang X: Dracorhodin perchlorate induces G1/G0 phase arrest
and mitochondria-mediated apoptosis in SK-MES-1 human lung squamous
carcinoma cells. Oncol Lett. 10:240–246. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yu JH, Zheng GB, Liu CY, Zhang LY, Gao HM,
Zhang YH, Dai CY, Huang L, Meng XY, Zhang WY and Yu XF: Dracorhodin
perchlorate induced human breast cancer MCF-7 apoptosis through
mitochondrial pathways. Int J Med Sci. 10:1149–1156. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Molinari M: Cell cycle checkpoints and
their inactivation in human cancer. Cell Prolif. 33:261–274. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kastan MB and Bartek J: Cell-cycle
checkpoints and cancer. Nature. 432:316–323. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Diaz-Moralli S, Tarrado-Castellarnau M,
Miranda A and Cascante M: Targeting cell cycle regulation in cancer
therapy. Pharmacol Ther. 138:255–271. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shaltiel IA, Krenning L, Bruinsma W and
Medema RH: The same, only different-DNA damage checkpoints and
their reversal throughout the cell cycle. J Cell Sci. 128:607–620.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hochegger H, Takeda S and Hunt T:
Cyclin-dependent kinases and cell-cycle transitions: Does one fit
all? Nat Rev Mol Cell Biol. 9:910–916. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wood SJ, Goldufsky JW, Bello D, Masood S
and Shafikhani SH: Pseudomonas aeruginosa ExoT induces
mitochondrial apoptosis in target host cells in a manner that
depends on its GTPase-activating protein (GAP) domain activity. J
Biol Chem. 290:29063–29073. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Nguyen JT and Wells JA: Direct activation
of the apoptosis machinery as a mechanism to target cancer cells.
Proc Natl Acad Sci USA. 100:7533–7538. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wong RS: Apoptosis in cancer: From
pathogenesis to treatment. J Exp Clin Cancer Res. 30:872011.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ola MS, Nawaz M and Ahsan H: Role of Bcl-2
family proteins and caspases in the regulation of apoptosis. Mol
Cell Biochem. 351:41–58. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lemke J, von Karstedt S, Zinngrebe J and
Walczak H: Getting TRAIL back on track for cancer therapy. Cell
Death Differ. 21:1350–1364. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xia MY, Wang MW, Cui Z, Tashiro SI,
Onodera S, Minami M and Ikejima T: Dracorhodin perchlorate induces
apoptosis in HL-60 cells. J Asian Nat Prod Res. 8:335–343. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
He Y, Ju W, Hao H, Liu Q, Lv L and Zeng F:
Dracorhodin perchlorate suppresses proliferation and induces
apoptosis in human prostate cancer cell line PC-3. J Huazhong Univ
Sci Technolog Med Sci. 31:2152011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Huynh J, Etemadi N, Hollande F, Ernst M
and Buchert M: The JAK/STAT3 axis: A comprehensive drug target for
solid malignancies. Semin Cancer Biol. 45:13–22. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Johnson DE, O'Keefe RA and Grandis JR:
Targeting the IL-6/JAK/STAT3 signalling axis in cancer. Nat Rev
Clin Oncol. 15:234–248. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Prabhu VV, Allen JE, Dicker DT and
El-Deiry WS: Small-molecule ONC201/TIC10 targets
chemotherapy-resistant colorectal cancer stem-like cells in an
Akt/Foxo3a/TRAIL-dependent manner. Cancer Res. 75:1423–1432. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Siveen KS, Sikka S, Surana R, Dai X, Zhang
J, Kumar AP, Tan BK, Sethi G and Bishayee A: Targeting the STAT3
signaling pathway in cancer: Role of synthetic and natural
inhibitors. Biochim Biophys Acta. 1845:136–154. 2014.PubMed/NCBI
|
|
36
|
Wei Z, Jiang X, Qiao H, Zhai B, Zhang L,
Zhang Q, Wu Y, Jiang H and Sun X: STAT3 interacts with Skp2/p27/p21
pathway to regulate the motility and invasion of gastric cancer
cells. Cell Signal. 25:931–938. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ma J, Song X, Xu X and Mou Y:
Cancer-associated-fibroblasts promote the chemo-resistance in
gastric cancer through secreting IL-11 targeting JAK/STAT3/Bcl2
pathway. Cancer Res Treat. 51:194–210. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Steelman LS, Pohnert SC, Shelton JG,
Franklin RA, Bertrand FE and McCubrey JA: JAK/STAT, Raf/MEK/ERK,
PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis.
Leukemia. 18:189–218. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
New DC, Wu K, Kwok AW and Wong YH: G
protein-coupled receptor-induced Akt activity in cellular
proliferation and apoptosis. FEBS J. 274:6025–6036. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Rathbone CR, Booth FW and Lees SJ: FoxO3a
preferentially induces p27Kip1 expression while impairing muscle
precursor cell-cycle progression. Muscle Nerve. 37:84–89. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhang X, Tang N, Hadden TJ and Rishi AK:
Akt, FoxO and regulation of apoptosis. Biochim Biophys Acta.
1813:1978–1986. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Li Y, Cui N, Zheng PS and Yang WT: BMX/Etk
promotes cell proliferation and tumorigenicity of cervical cancer
cells through PI3K/AKT/mTOR and STAT3 pathways. Oncotarget.
8:49238–49252. 2017.PubMed/NCBI
|
|
43
|
Steelman LS, Abrams SL, Whelan J, Bertrand
FE, Ludwig DE, Bäsecke J, Libra M, Stivala F, Milella M, Tafuri A,
et al: Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and
Jak/STAT pathways to leukemia. Leukemia. 22:686–707. 2008.
View Article : Google Scholar : PubMed/NCBI
|
